Association of cytochrome P450 2E1 genetic polymorphisms with squamous cell carcinoma of the oesophagus
-
Dongping Li
Abstract
Squamous cell carcinoma of the oesophagus is one of the most common cancers among black males in South Africa. Genetic polymorphism in the cytochrome P450 2E1 (CYP2E1) gene, coding for one of the main enzymes involved in the bioactivation of tobacco- and alcohol-related substances, was investigated for its role in the development of oesophageal cancer. Three single nucleotide polymorphisms −1053C→T, −1293G→A (both give rise to CYP2E1*5) and 7632T→A ( CYP2E1*6) in the 5′-untranslated region of CYP2E1 were investigated in 189 patients and 198 control individuals in South Africa. The mutant variants occurred between patients and controls at frequencies of 1% and 2% (−1053C→T), 1% and 3% (−1293G→A) and 18% and 7% (7632T→A), respectively. In comparing patients with controls, the heterozygous CYP2E1*6 genotype was associated with increased risk of the development of squamous cell carcinoma of the oesophagus (odds ratio, 5.90; p<0.001) after adjusting for age, sex, smoking and alcohol consumption. In contrast, we did not find a significant association between CYP2E1*5 and oesophageal cancer. Six novel mutations, −1371G→A, −1359C→G, −1342C→G, −1261T→del, −1189T→C and −1103C→G, were identified by DNA sequence analysis of the CYP2E1 promoter region. In summary, our case-control study of oesophageal cancer revealed an elevated risk associated with the CYP2E1*6 allele in South Africans.
References
1 Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of the 25 major cancers in 1990. Int J Cancer 1999; 80: 827–41. 10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-PSearch in Google Scholar
2 Pinto LF, Rossini AM, Albano RM, Felzenszwalb I, Gallo CV, Nunes RA, et al. Mechanisms of esophageal cancer development in Brazilians. Mutat Res 2003; 544: 365–73. 10.1016/j.mrrev.2003.06.021Search in Google Scholar
3 Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37: S4–S66. 10.1016/S0959-8049(01)00267-2Search in Google Scholar
4 Hendricks D, Parker MI. Oesophageal cancer in Africa. IUBMB Life 2002; 53: 263–8. 10.1080/15216540212643Search in Google Scholar
5 Allen JW, Richardson JD, Edwards MJ. Squamous cell carcinoma of the oesophagus: a review and update. Surg Oncol 1997; 6: 193–200. 10.1016/S0960-7404(98)00003-6Search in Google Scholar
6 Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994; 270: 414–23. Search in Google Scholar
7 Lechevrel M, Casson AG, Wolf CR, Hardie LJ, Flinterman MB, Montesano R, et al. Characterisation of cytochrome P450 expression in human oesophageal mucosa. Carcinogenesis 1999; 20: 243–8. 10.1093/carcin/20.2.243Search in Google Scholar
8 Guengerich FP. Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes. Chem Res Toxicol 1991; 4: 391–407. 10.1021/tx00022a001Search in Google Scholar
9 Lieber CS. Cytochrome P4502E1: its physiological and pathological role. Physiol Rev 1997; 77: 517–44. 10.1152/physrev.1997.77.2.517Search in Google Scholar
10 Yang CS, Yoo JS, Ishizaki H, Hong JY. Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanism of regulation. Drug Metab Rev 1990; 22: 147–59. 10.3109/03602539009041082Search in Google Scholar
11 Crespi CL, Penman BW, Gelboin HV, Gonzalez FJ. A tobacco smoke derived nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P450 2D6. Carcinogenesis 1991; 12: 1197–201. 10.1093/carcin/12.7.1197Search in Google Scholar
12 Bolt HM, Roos PH, Their R. The cytochrome P450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and industrial medicine. Int Arch Occup Environ Health 2003; 76: 174–85. 10.1007/s00420-002-0407-4Search in Google Scholar
13 Hayashi S, Watanabe J, Kawajiri K. Genetic polymorphism in the 5′-flanking region changes the transcriptional regulation of the human cytochrome P450 2E1 gene. J Biochem 1991; 110: 559–65. 10.1093/oxfordjournals.jbchem.a123619Search in Google Scholar
14 Uematsu F, Kikuchi H, Motomiya M, Abe T, Sagami I, Omachi T, et al. Association between restriction fragment length polymorphism of the human cytochrome P450 2E1 gene and susceptibility to lung cancer. Jpn J Cancer Res 1991; 82: 254–6. 10.1111/j.1349-7006.1991.tb01838.xSearch in Google Scholar
15 Neuhaus T, Ko Y-D, Lorenzen K, Fronhoffs S, Harth V, Brode P, et al. Association of cytochrome P450 2E1 polymorphisms with head and neck squamous cell cancer. Toxicol Lett 2004; 151: 273–82. 10.1016/j.toxlet.2003.09.017Search in Google Scholar
16 Watanabe J, Hayashi S, Nakachi K, Imai K, Suda Y, Sekine T, et al. PstI and RsaI RFLPs in complete linkage disequilibrium at the CYP2E gene. Nucleic Acids Res 1990; 18: 7194. 10.1093/nar/18.23.7194Search in Google Scholar
17 Watanabe J, Hayashi SI, Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanking region. Biochem J 1994; 116: 321–6. 10.1093/oxfordjournals.jbchem.a124526Search in Google Scholar
18 Marchand LL, Sivaraman L, Pierce L, Seifried A, Lum A, Wilkens LR, et al. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 1998; 58: 4858–63. Search in Google Scholar
19 Huang Y-S, Chern H-D, Su W-J, Chang S-C, Chang C-H, Chang F-Y, et al. Cytochrome P450 2E1 and susceptibility to antituberculosis drug-induced hepatitis. Hepatology 2003; 37: 924–30. 10.1053/jhep.2003.50144Search in Google Scholar
20 Morita S, Yano M, Shiozaki H, Tsujinaka T, Ebisui C, Morimoto T, et al. CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous cell carcinoma of the esophagus. Int J Cancer 1997; 71: 192–5. 10.1002/(SICI)1097-0215(19970410)71:2<192::AID-IJC11>3.0.CO;2-KSearch in Google Scholar
21 Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Baranova H, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomark Prev 2001; 10: 1239–48. Search in Google Scholar
22 Ballo R, Li DP, Parker MI. Genotyping of alcohol dehydrogenase type 2 and 3 using a two-buffer polyacrylamide gel electrophoresis system. Clin Chem Lab Med 2003; 41: 298–301. 10.1515/CCLM.2003.047Search in Google Scholar
23 Carriere V, Berthou F, Baird S, Belloe C, Beaune P, Waziers I. Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype. Pharmacogenetics 1996; 6: 203–11. 10.1097/00008571-199606000-00002Search in Google Scholar
24 Kim RB, Yamazaki H, Chiba K, O'Shea D, Mimura M, Guengerich FP, et al. In vivo and in vitro characterisation of CYP2E1 activity in Japanese and Caucasians. J Pharmacol Exp Ther 1996; 279: 4–11. Search in Google Scholar
25 Their R, Lewalter J, Selinski S, Bolt HM. Possible impact of human CYP2E1 polymorphisms on the metabolism of acrylonitrile. Toxicol Lett 2002; 128: 249–55. 10.1016/S0378-4274(01)00546-XSearch in Google Scholar
26 Dandara C, Masimirembwa CM, Magimba A, Kaaya S, Sayi J, de Sommers K, et al. Arylamine N-acetyltransferase (NAT2) genotypes in Africans: the identification of a new allele with nucleotide changes 481C>T and 590G>A. Pharmacogenetics 2003; 13: 55–8. 10.1097/00008571-200301000-00008Search in Google Scholar
27 Wooding SP, Watkins WS, Bamshad MJ, Dunn DM, Weiss RB, Jorde LB. DNA sequence variation in a 3.7-kb noncoding sequence 5′ of the CYP1A2 gene: implications for human population history and natural selection. Am J Hum Genet 2002; 71: 528–42. 10.1086/342260Search in Google Scholar
28 Shields PG, Ambrosone CB, Graham S, Bowman ED, Harrington AM, Gillenwater KA, et al. A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer. Mol Carcinogen 1996; 17: 144–50. 10.1002/(SICI)1098-2744(199611)17:3<144::AID-MC6>3.0.CO;2-FSearch in Google Scholar
29 Yu M-W, Gladek-Yarborough A, Chiampraset S, Santella RM, Liaw Y-F, Chen C-J. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroentrology 1995; 109: 1266–73. 10.1016/0016-5085(95)90587-1Search in Google Scholar
30 Hung HC, Chuang J, Chien YC, Chern HD, Chiang CP, Kuo YS, et al. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT; environmental factors and risk of oral cancer. Cancer Epidemiol Biomark Prev 1997; 6: 901–5. Search in Google Scholar
31 Persson I, Johansson I, Bergling H, Dahl ML, Seidegard J, Rylander R, et al. Genetic polymorphism of cytochrome P4502E1 in a Swedish population: relationship to incidence of lung cancer. FEBS Lett 1993; 319: 207–11. 10.1016/0014-5793(93)80547-8Search in Google Scholar
32 Adams CH, Werely CJ, Victor TC, Hoal EG, Rossouw G, van Helden PD. Allele frequencies for glutathione S-transferase and N-acetyltransferase 2 differ in African population groups and may be associated with oesophageal cancer or tuberculosis incidence. Clin Chem Lab Med 2003; 41: 600–5. 10.1515/CCLM.2003.090Search in Google Scholar
33 Dandara C, Sayi J, Masimirembwa CM, Magimba A, Kaaya S, De Sommers K, et al. Genetic polymorphism of cytochrome P450 1A1 (Cyp1A1) and glutathione transferases (M1, T1 and P1) among Africans. Clin Chem Lab Med 2002; 40: 952–7. 10.1515/CCLM.2002.167Search in Google Scholar
© by Walter de Gruyter Berlin New York
Articles in the same Issue
- Autoantibodies against intrinsic factor (IF) measured with an ELISA using recombinant human IF as both catching and detecting reagent
- Antibody titer against malondialdehyde-modified LDL compares with HDL cholesterol concentration in identifying angiographically verified coronary artery disease. Comparison of tests by ROC analysis
- Fucosylation of serum glycoproteins in lung cancer patients
- Association of cytochrome P450 2E1 genetic polymorphisms with squamous cell carcinoma of the oesophagus
- α-Tocopherol as an antiretroviral therapy supplement for HIV-1-infected patients for increased lymphocyte viability
- The effect of antioxidant supplementation on superoxide dismutase activity, Cu and Zn levels, and total antioxidant status in erythrocytes of patients with Graves' disease
- Concentrations of calcium, copper, iron, magnesium, potassium, sodium and zinc in adult female hair with different body mass indexes in Taiwan
- Estimation of the limit of detection with a bootstrap-derived standard error by a partly non-parametric approach. Application to HPLC drug assays
- Pitfall in the high-throughput quantification of whole blood cyclosporin A using liquid chromatography-tandem mass spectrometry
- How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?
- An iterative method for improved estimation of the mean of peer-group distributions in proficiency testing
- Impact of a common CV evaluation scheme on overall laboratory performance: 8-year experience of a large national proficiency testing program in Japan
- Significance of small dense low-density lipoproteins as coronary risk factor in diabetic and non-diabetic Korean populations
- Evaluation of a rapid bedside test for the quantitative determination of C-reactive protein
- Power function of the reference change value in relation to cut-off points, reference intervals and index of individuality
- Erythrocyte ferritin concentration: analytical performance of the immunoenzymatic IMx-Ferritin (Abbott) assay
- Vitamin C and aberrant electrolyte results
- POX-ACT assay and d-ROMs test: comparison impossible
- A spectrophotometric micromethod for determining erythrocyte protoporphyrin-IX in whole blood or erythrocytes
Articles in the same Issue
- Autoantibodies against intrinsic factor (IF) measured with an ELISA using recombinant human IF as both catching and detecting reagent
- Antibody titer against malondialdehyde-modified LDL compares with HDL cholesterol concentration in identifying angiographically verified coronary artery disease. Comparison of tests by ROC analysis
- Fucosylation of serum glycoproteins in lung cancer patients
- Association of cytochrome P450 2E1 genetic polymorphisms with squamous cell carcinoma of the oesophagus
- α-Tocopherol as an antiretroviral therapy supplement for HIV-1-infected patients for increased lymphocyte viability
- The effect of antioxidant supplementation on superoxide dismutase activity, Cu and Zn levels, and total antioxidant status in erythrocytes of patients with Graves' disease
- Concentrations of calcium, copper, iron, magnesium, potassium, sodium and zinc in adult female hair with different body mass indexes in Taiwan
- Estimation of the limit of detection with a bootstrap-derived standard error by a partly non-parametric approach. Application to HPLC drug assays
- Pitfall in the high-throughput quantification of whole blood cyclosporin A using liquid chromatography-tandem mass spectrometry
- How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?
- An iterative method for improved estimation of the mean of peer-group distributions in proficiency testing
- Impact of a common CV evaluation scheme on overall laboratory performance: 8-year experience of a large national proficiency testing program in Japan
- Significance of small dense low-density lipoproteins as coronary risk factor in diabetic and non-diabetic Korean populations
- Evaluation of a rapid bedside test for the quantitative determination of C-reactive protein
- Power function of the reference change value in relation to cut-off points, reference intervals and index of individuality
- Erythrocyte ferritin concentration: analytical performance of the immunoenzymatic IMx-Ferritin (Abbott) assay
- Vitamin C and aberrant electrolyte results
- POX-ACT assay and d-ROMs test: comparison impossible
- A spectrophotometric micromethod for determining erythrocyte protoporphyrin-IX in whole blood or erythrocytes
